A mammalian protein targeted by G1-arresting rapamycin–receptor complex

[1]  J. Kunz,et al.  TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. , 1994, Molecular biology of the cell.

[2]  J. Thorner,et al.  Phosphatidylinositol 4-kinase: gene structure and requirement for yeast cell viability. , 1993, Science.

[3]  S. Schreiber,et al.  An FKBP‐Rapamycin‐Sensitive, Cyclin‐Dependent Kinase Activity that Correlates with the FKBP‐Rapamycin‐Induced G1 Arrest Point in MG‐63 Cells a , 1993, Annals of the New York Academy of Sciences.

[4]  R. Abraham,et al.  Rapamycin inhibition of interleukin-2-dependent p33cdk2 and p34cdc2 kinase activation in T lymphocytes. , 1993, The Journal of biological chemistry.

[5]  S. Schreiber,et al.  FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line. , 1993, The Journal of biological chemistry.

[6]  S. Danishefsky,et al.  Total synthesis of rapamycin via a novel titanium-mediated aldol macrocyclization reaction , 1993 .

[7]  M. Mclaughlin,et al.  Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity , 1993, Molecular and cellular biology.

[8]  H. Lane,et al.  p70s6k function is essential for G1 progression , 1993, Nature.

[9]  J. Kunz,et al.  Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression , 1993, Cell.

[10]  R. Abraham,et al.  Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1/S-phase growth arrest in T lymphocytes. , 1993, The Journal of biological chemistry.

[11]  F. Poor,et al.  Calcineurin mediates inhibition by FK506 and cyclosporin of recovery from α-factor arrest in yeast , 1992, Nature.

[12]  T. Hultsch,et al.  The effect of the immunophilin ligands rapamycin and FK506 on proliferation of mast cells and other hematopoietic cell lines. , 1992, Molecular biology of the cell.

[13]  C. Crews,et al.  Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Avruch,et al.  Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. , 1992, Science.

[15]  S. Schreiber.  Immunophilin-sensitive protein phosphatase action in cell signaling pathways , 1992, Cell.

[16]  G. Crabtree,et al.  Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase , 1992, Nature.

[17]  G. Crabtree,et al.  Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases , 1992, Cell.

[18]  T. Starzl,et al.  Effects of rapamycin on cultured hepatocyte proliferation and gene expression , 1992, Hepatology.

[19]  S. Schreiber,et al.  A rapamycin-selective 25-kDa immunophilin. , 1992, Biochemistry.

[20]  P. Nurse,et al.  Animal cell cycles and their control. , 1992, Annual review of biochemistry.

[21]  J. Heitman,et al.  Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast , 1991, Science.

[22]  S. Schreiber,et al.  Chemistry and biology of the immunophilins and their immunosuppressive ligands. , 1991, Science.

[23]  L A Herzenberg,et al.  Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[24]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[25]  N. Sigal,et al.  Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. , 1990, Journal of immunology.

[26]  J. Devereux,et al.  A comprehensive set of sequence analysis programs for the VAX , 1984, Nucleic Acids Res..

[27]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .